SCHEDULE: T. Rowe Price Adjusts Revvity Stake to 9.2%

T. Rowe Price Investment Management, Inc. has filed a Schedule 13G, reporting a beneficial ownership of 9.2% in Revvity Inc. common stock.

Summary

• T. Rowe Price Investment Management, Inc. has filed an amendment to its Schedule 13G, indicating a change in its beneficial ownership of Revvity Inc. common stock.
• The filing reports that T. Rowe Price Investment Management, Inc. now beneficially owns 10,261,343 shares of Revvity Inc. common stock.
• This represents 9.2% of the class of securities.
• The filing is an amendment (Amendment No. 9) and the event date requiring the filing is August 31, 2026.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as neutral to slightly negative, as it primarily reports a change in beneficial ownership without new strategic information or performance updates.

Positives

• T. Rowe Price Investment Management, Inc. continues to hold a significant stake in Revvity Inc., suggesting ongoing confidence in the company's long-term prospects.
• The reporting entity is a well-established investment manager, indicating a professional and strategic approach to its holdings.

Negatives

• The filing does not provide any new financial performance data or strategic updates for Revvity Inc., making it difficult to assess the company's current operational health.
• The change in beneficial ownership, while reported, does not inherently signal positive or negative performance for Revvity Inc. itself.

Risks

• As an investment manager, T. Rowe Price's holdings are subject to market fluctuations and investment strategy changes, which could lead to further adjustments in their stake.
• The filing does not detail the specific reasons for the change in beneficial ownership, leaving room for speculation about the underlying investment thesis.

Future Outlook

This filing is a report of beneficial ownership and does not contain forward-looking statements or guidance from Revvity Inc. management regarding future performance.

Management Comments

• T. Rowe Price Investment Management, Inc. hereby declares and affirms that the filing of Schedule 13G shall not be construed as an admission that Price Investment Management is the beneficial owner of the securities referred to, which beneficial ownership is expressly denied.
• Ellen York, Vice President of T. Rowe Price Investment Management, Inc., certified the accuracy of the filing.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors and signal changes in significant shareholdings. This filing indicates T. Rowe Price Investment Management, Inc. is a substantial holder in the healthcare technology sector, represented by Revvity Inc.

Comparison to Industry Standards

• Institutional ownership percentages vary by industry and company maturity. A 9.2% stake by a major asset manager like T. Rowe Price is significant and often seen in companies with established market positions.
• Competitors in the healthcare technology space, such as Thermo Fisher Scientific or Danaher Corporation, also attract substantial institutional investment, though specific ownership percentages fluctuate based on market conditions and company performance.

Stakeholder Impact

• Shareholders: The filing indicates a significant institutional investor's stake, which can influence market perception and stock liquidity. Changes in this stake may signal shifts in institutional sentiment.
• Management of Revvity Inc.: The presence of a large institutional holder like T. Rowe Price can bring scrutiny and influence corporate governance discussions.
• Investment Community: This filing provides transparency on major ownership changes, aiding analysts and investors in their assessments.

Next Steps

• T. Rowe Price Investment Management, Inc. will continue to manage its investment in Revvity Inc. according to its investment strategies.
• Future amendments to Schedule 13G will be filed if there are further material changes in beneficial ownership.

Key Dates

Keywords

Revvity Inc., T. Rowe Price, Schedule 13G, Beneficial Ownership, Investment Management, Common Stock, Securities Exchange Act